The following list contains an estimated subset of Syneos Health studies which are currently in progress or have been completed within the last 5 years, based upon the selected parameters above. Studies owned by our Early Phase Business Unit are not included in these results. The data below is organized by Indication and further by Sub-Indication. Please note that studies can contain more than one Indication, which may not be directly aligned with the Therapeutic Area selected. This is because there are secondary indications associated with these studies that are aligned to the Therapeutic Area.